Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
paolo tarantino
Sep 15, 2024, 08:33 |
Drugs
Paolo Tarantino: Some HER2+ tumors melt upon dual anti-HER2 Treatment
Paolo Tarantino shared on X: "Some HER2+ tumors melt upon dual anti-HER2 Treatment; others require…
Sep 14, 2024, 19:28 |
Insight
Paolo Tarantino: Are all residual diseases equal?
Paolo Tarantino shared on LinkedIn: “ Patients with residual breast cancer after neoadjuvant treatment harbor…
Sep 14, 2024, 06:35 |
Opinion
Paolo Tarantino: Interesting data with TROP2 quantitative continuous scoring to predict Dato-DXd activity in lung cancer
Paolo Tarantino posted the following on X: “Interesting data with TROP2 quantitative continuous scoring (QCS)…
Sep 13, 2024, 07:23 |
Blog
Paolo Tarantino: List for the upcoming early-phase ADCs at ESMO24
Paolo Tarantino shared a post by Raffaele Colombo on X, adding: "Terrific list of ADC data to…
Sep 10, 2024, 06:01 |
Insight
Paolo Tarantino: A Special Collection for ADCs in Breast Oncology for Nature Portfolio
Paolo Tarantino shared on LinkedIn: "The field of ADCs is still at its dawn. Many…
Sep 7, 2024, 11:16 |
Drugs
Paolo Tarantino: Recommended read on adjuvant ribociclib in preparation for the ESMO24
Oncology Brothers shared a post by Paolo Tarantino on X, adding: “Adjuvant abemaciclib preferred for…
Sep 6, 2024, 11:25 |
Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
Sep 5, 2024, 15:22 |
Blog
Paolo Tarantino: Looking forward to join the Medscape symposium to review treatment landscape for HR+/HER2- metastatic breast cancer
Paolo Tarantino shared a post on LinkedIn: "Really looking forward to joining this Medscape symposium to…
Sep 4, 2024, 15:08 |
Blog
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Paolo Tarantino shared a post on LinkedIn: "Two weeks to ESMO 2024. Multiple important breast…
Aug 18, 2024, 07:29 |
Blog
,
Opinion
Paolo Tarantino: Do all patients with TNBC need 5 neoadjuvant drugs + 1 year of IO?
Paolo Tarantino shared a post on X about recent paper by Marleen Kok et al., titled…
1
2
3
4
5
All:
205
Posts:
1 - 10
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube